Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 07:37:52 +0200Wed, 26 Jun 2024 18:05:00 +0200Supemtek : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5159_en_1.pdfSupemtek : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5159_en_1.pdfWed, 26 Jun 2024 18:05:00 +0200Human medicineHuman medicines European public assessment report (EPAR): Supemtek, Quadrivalent influenza vaccine (recombinant, prepared in cell culture), Date of authorisation: 16/11/2020, Revision: 5, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/supemtekHuman medicines European public assessment report (EPAR): Supemtek, Quadrivalent influenza vaccine (recombinant, prepared in cell culture), Date of authorisation: 16/11/2020, Revision: 5, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/supemtekWed, 26 Jun 2024 13:05:00 +0200Human medicine